white paper

Preventable Tragedies

Abstract

The horrific murders of Rob Reiner and his wife, Michele, by their son are made more tragic because they were preventable.

Nick Reiner, Rob’s son, began his downward spiral to murder at age 15. His eighteen attempts at failed rehabilitation are typical of the 1.36 million patients going through Rehabilitation Programs to address their Substance Use Disorder (SUD).

Drug Rehabilitation is now a $35 billion global industry. Americans spent $9.44 billion on patient rehabilitation treatments in 2024. U.S. Rehab spending is expected to rise to $16.22 billion by 2033. Another $1.5 billion is allocated in Federal grants for Opioid Response Programs.

Approximately 60 percent of those who complete rehab programs relapse into addiction. Only 43 percent of those who enter rehab programs complete their treatment.

These multiple levels of failure have only motivated government and private foundations to spend more money pursuing the same approaches. How many more lives will be lost before there is meaningful change?

It does not have to be this way.

Read More on citizenoversight.blogspot.com or download the PDF.

white paper

Does Red-Light Therapy Work?

Abstract

Follow any beauty biohacker on social media right now and you’ll hear them raving about the benefits of

As an increasingly popular longevity tool, red-light therapy is said to help improve skin and hair health, enhance cellular vitality, and reverse the signs of aging. While there is evidence to support the claims of red-light therapy, studies are limited. To discover best practice when it comes to red-light therapy and how to make it work into our everyday lives, we asked the experts to share insight into its effectiveness.

Read More on wired.com or download the PDF.

white paper

For those living with long-term brain injuries, a new therapy may offer a path forward

Abstract

SACRAMENTO, Calif. — Rico Petrini remembers the early days of high school football — the excitement, the intensity and the hits that came with playing linebacker. Back then, he said, getting “your bell rung” was something teammates laughed about.

“I probably had at least 8 to 10 concussions in high school,” Petrini said. “We used to laugh about, oh, he’s seeing stars.”

Football was more than a sport for him. He studied it, lived it, and eventually drew the attention of more than 100 colleges. He chose Oregon State, but by the time he stepped onto the field there, he said the damage had already piled up.

Read More on abc10.com or download the PDF.

The People and Hope of MAHA

Gibby Media Group

white paper

The Pope, who was forced into a wheelchair was put on his feet with his therapy of Hungarian professor

Abstract

On the tenth anniversary of his election, Pope Francis recovered. Literally. He spent the last year in a wheelchair due to his severe knee problems, he was unable to walk because of his severe pain, he almost turned the thought of retiring in his head. But then he was cured by the therapy of a brilliant Hungarian medical professor. On-site report from the inventor’s son’s office.

31 December, XVI. For the first time since Benedict’s death, Pope Francis gave an interview. The 86-year-old Catholic pope told Sky News. The essence of the cheerful monologue was that the old man was healed, that the patient was a successful therapy for his knees, and he could get up from the wheelchair, where he was forced to do about a year ago.

Read More on index.hu

white paper

Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)

Abstract

GENEVA – (BUSINESS WIRE) – Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced its intention to acquire LumiThera, Inc., a leader in light-based innovations for ophthalmology, and its PBM device for the treatment of early and intermediate dry AMD.1 LumiThera’s PBM is the only device that has demonstrated meaningful vision improvement compared to baseline for people living with early to intermediate dry AMD.2,* Dry AMD is a progressive disease typically treated in late stage, with limited treatment options.2

 

Read More on businesswire.com or download the PDF.

white paper

Harnessing Medical Innovation to Make America Healthy Again

Abstract

Join The Heritage Foundation and leading medical scientists for a discussion of cutting edge medical technology and its wider implementation to make Americans healthier. Photobiomodulation (PBM) and hyperbaric oxygen therapy (HBOT) are two proven treatments that stimulate cell growth in patients suffering from a vast array of conditions. Managing pain, promoting wound healing, and treating brain injuries are just a few of the applications for these treatments.

 

Read More on heritage.org or download the PDF.

white paper

Photobiomodulation Clinic at Mass General Offers a Promising New Treatment for Neuropsychiatric Disorders

Abstract

Transcranial photobiomodulation (PBM) is emerging as an innovative approach to treat various neuropsychiatric conditions, including major depressive disorder, generalized anxiety disorder, traumatic brain injury, and Alzheimer’s disease and other types of dementia. The Brain Photobiomodulation Clinic at Mass General Hospital, under the direction of Paolo Cassano, MD, PhD, offers this cutting-edge treatment for patients with treatment-resistant neuropsychiatric disorders.

 

Read More on mghpsychnews.org or download the PDF.

white paper

Lighting the Way to a Healthier America

Abstract

The Make America Healthy Again (MAHA) movement is now national policy with Trump establishing the MAHA Commission and Robert F. Kennedy, Jr. as the Secretary of the Department of Health & Human Services (HHS).

Americans are universally concerned about their health, but well-financed and entrenched interests are thwarting MAHA. Big Pharma spends $400 million a year on lobbying and contributes $90 million each election cycle. Big food spends $130 million a year on lobbying and contributes $42.5 million each election cycle.

 

Read More on citizenoversight.blogspot.com or download the PDF.

white paper

Local athletes to be subjects of new, international study

Abstract

SHEPHERDSTOWN — Athletes from Shepherd University will soon be some of the subjects of a new study being conducted by photobiomodulation (PBM) therapy researchers.

According to Ann Liebert, who is the coordinator of photomolecular research at Sydney Adventist Hospital in Australia, the research will focus on whether or not PBM therapy heals concussions.

 

Read More on journal-news.net or download the PDF.